Cigna Group - COMMON STOCK (CI) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
CI on NYSE
Shares outstanding
266,638,899
Price per share
$271.24
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
233,961,759
Total reported value
$64,393,270,422
% of total 13F portfolios
0.04%
Share change
+1,630,802
Value change
+$420,770,546
Number of holders
1,609
Price from insider filings
$271.24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Cigna Group - COMMON STOCK (CI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 9.6% $8,770,917,240 26,153,737 The Vanguard Group 31 Mar 2025
BlackRock, Inc. 7.4% $6,687,563,331 19,941,446 BlackRock, Inc. 31 Mar 2025
FMR LLC 4% $3,074,346,505 10,665,556 FMR LLC 30 Sep 2025

As of 31 Dec 2025, 1,609 institutional investors reported holding 233,961,759 shares of Cigna Group - COMMON STOCK (CI). This represents 88% of the company’s total 266,638,899 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cigna Group - COMMON STOCK (CI) together control 62% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.8% 26,173,577 +1.6% 0.1% $7,203,753,597
BlackRock, Inc. 8.7% 23,184,007 +4.9% 0.11% $6,380,934,226
STATE STREET CORP 4.6% 12,339,250 +1.8% 0.11% $3,396,131,778
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 4.4% 11,805,083 +8.3% 1% $3,249,112,994
FMR LLC 4.3% 11,433,649 +7.2% 0.16% $3,146,883,422
Dodge & Cox 4.2% 11,138,614 +20% 1.7% $3,065,680,742
Sanders Capital, LLC 2.9% 7,801,089 -0.35% 2.5% $2,147,093,725
GQG Partners LLC 2.9% 7,763,295 +14% 3.5% $2,136,698,563
PRICE T ROWE ASSOCIATES INC /MD/ 2.4% 6,270,213 -45% 0.19% $1,725,752,000
GEODE CAPITAL MANAGEMENT, LLC 2.3% 6,051,370 +0.81% 0.1% $1,658,054,581
JPMORGAN CHASE & CO 2.1% 5,639,215 -15% 0.1% $1,552,081,573
NORGES BANK 1.4% 3,705,227 0.11% $1,019,789,627
MORGAN STANLEY 1.3% 3,387,860 -8% 0.06% $932,441,729
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 2,958,656 +9.8% 0.48% $814,310,891
BANK OF AMERICA CORP /DE/ 1.1% 2,925,406 +3.4% 0.06% $805,159,582
NORTHERN TRUST CORP 1% 2,751,024 -2.7% 0.1% $757,164,336
AMERIPRISE FINANCIAL INC 0.92% 2,443,642 +14% 0.15% $672,566,887
Invesco Ltd. 0.91% 2,421,775 +27% 0.1% $666,545,180
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.87% 2,325,173 +1% 0.14% $639,957,366
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.82% 2,192,063 +4% 0.09% $603,321,532
DIMENSIONAL FUND ADVISORS LP 0.82% 2,189,878 +2.6% 0.13% $602,747,274
Legal & General Group Plc 0.76% 2,036,852 +1.3% 0.12% $560,602,783
Nuveen, LLC 0.76% 2,014,163 +14% 0.15% $554,358,083
Grantham, Mayo, Van Otterloo & Co. LLC 0.73% 1,958,134 +20% 1.4% $538,937,572
Capital Research Global Investors 0.73% 1,933,645 -39% 0.1% $532,197,113

Institutional Holders of Cigna Group - COMMON STOCK (CI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 233,961,759 $64,393,270,422 +$420,770,546 $275.23 1,609
2025 Q3 232,903,013 $67,146,460,371 -$859,604,229 $288.25 1,596
2025 Q2 234,889,680 $77,598,726,972 -$885,212,933 $330.58 1,704
2025 Q1 237,606,738 $78,165,391,200 -$1,629,993,633 $329.00 1,662
2024 Q4 243,110,253 $67,139,294,537 +$149,546,680 $276.14 1,620
2024 Q3 241,501,769 $83,663,034,570 -$782,370,817 $346.44 1,676
2024 Q2 242,938,363 $80,300,760,069 -$2,109,254,634 $330.57 1,640
2024 Q1 249,797,666 $90,679,981,393 -$1,122,160,345 $363.19 1,636
2023 Q4 254,905,490 $76,350,472,759 -$323,521,351 $299.45 1,607
2023 Q3 255,571,910 $73,157,868,502 -$415,321,371 $286.07 1,478
2023 Q2 256,478,311 $71,887,572,718 +$121,205,524 $280.60 1,472
2023 Q1 256,474,460 $65,550,273,339 -$1,402,712,627 $255.53 1,457
2022 Q4 261,971,976 $86,695,724,570 -$2,552,637,868 $331.34 1,529
2022 Q3 270,855,350 $75,242,136,697 -$1,620,088,258 $277.47 1,452
2022 Q2 276,429,732 $72,853,453,449 -$283,725,559 $263.52 1,410
2022 Q1 278,899,427 $66,890,029,883 -$1,137,305,493 $239.61 1,346
2021 Q4 283,619,322 $65,152,838,427 -$1,812,537,350 $229.63 1,307
2021 Q3 291,305,903 $58,341,683,644 -$2,024,570,950 $200.16 1,219
2021 Q2 300,814,030 $71,290,214,867 -$1,665,379,799 $237.07 1,262
2021 Q1 307,283,997 $74,271,008,939 -$1,668,241,583 $241.74 1,216
2020 Q4 315,379,158 $65,634,524,310 -$626,660,034 $208.18 1,175
2020 Q3 319,448,567 $54,030,116,575 -$2,336,334,165 $169.41 1,089
2020 Q2 332,373,272 $62,333,055,611 +$389,410,042 $187.65 1,131
2020 Q1 330,640,915 $58,568,219,801 -$573,938,971 $177.18 1,105
2019 Q4 333,347,680 $68,149,790,920 +$764,945,588 $204.49 1,148
2019 Q3 328,919,099 $49,917,839,260 -$549,118,085 $151.79 1,018
2019 Q2 332,629,799 $52,411,348,146 -$84,749,971 $157.55 1,031
2019 Q1 336,095,513 $54,037,429,873 +$225,933,374 $160.82 1,063
2018 Q4 332,747,054 $63,187,552,217 +$63,024,351,645 $189.92 1,117
2018 Q3 3,821 $738,099 +$4,998 $208.25 6
2018 Q2 3,797 $669,426 -$1,436,787 $169.95 6
2018 Q1 12,737 $2,101,708 +$1,476,355 $167.74 7
2017 Q4 3,562 $675,935 -$24,108 $202.69 6
2017 Q3 3,681 $676,005 +$386,000 $186.94 6
2017 Q2 1,549 $258,553 +$7,500 $167.39 5
2017 Q1 1,504 $220,757 -$5,024 $146.49 5
2016 Q4 1,538 $204,723 -$12,735 $133.39 5
2016 Q3 1,419 $184,432 -$6,516 $130.15 4
2016 Q2 1,092 $140,000 -$134,560 $127.99 3
2016 Q1 2,014 $288,594 $137.47 4